Taipei, Thursday, Mar 09, 2021, 17:53

News

MOST Taiwan Tech Arena Leads 12 Medical Startups for the MedTech Conference 2019

Published: Sep 23,2019

TAIPEI, Taiwan - 12 medtech innovation startups, supported by The Ministry of Science and Technology (MOST), will attend the MedTech Conference 2019, showcasing their innovative tech solutions under name of Taiwan Tech Arena Pavilion (TTA Pavilion).

More on This

Taiwan Government Leading 100 Startups For CES2021

TAIPEI, Taiwan - In 2020, the global economy faced the impacts of the COVID-19 pandemic and the US-China trade war. While the economies around the world were critically affected...

MOST Assists Young Talents of Taiwan to Establish Global Influence

The Executive Yuan 11th National Science and Technology Conference ended successfully in December 2020. There are many important consensuses of topic in conclusion...

Held in Boston, the MedTech conference is one of the most influential medtech innovation events in the world, attracting more than 35 countries, 300 world-class speakers and 3,000 representatives from medtech related industries each year.

Recently, Taiwan quickly shifts from its advantage from hardware to software, and it is set to become Asia’s hotbed for AI development. TTA has coordinated Taiwan’s technology and startup resources and will have its pavilion during the MedTech Conference 2019. The TTA Pavilion has gathered some of the best minds in medtech and it is sure to be one of the must-sees to discover the latest trends and tech innovation.

After the MedTech Conference 2019, TTA also arrange Demo Day, team visits and meetings with locals such as MetroWest Medical Center, Carruth Capital, Boston Scientific, Mass Medic, Massachusetts Life Sciences Center, Massachusetts General Hospital etc., showcasing Taiwan’s best innovation to Boston.

CTIMES loves to interact with the global technology related companies and individuals, you can deliver your products information or share industrial intelligence. Please email us to en@ctimes.com.tw

933 viewed

comments powered by Disqus